Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Large Language Models for Controllable Multi-property Multi-objective Molecule Optimization.

Findings of ACL. EMNLP. Conference on Empirical Methods in Natural Language Processing·2026

Same author

log-RRIM: Yield Prediction via Local-to-Global Reaction Representation Learning and Interaction Modeling.

Journal of chemical information and modeling·2025

Same author

Major complications of percutaneous native and transplant kidney biopsy: a complete 10-year national prospective cohort study.

Clinical kidney journal·2025

Same author

RLSynC: Offline-Online Reinforcement Learning for Synthon Completion.

Journal of chemical information and modeling·2024

Same author

Enhancing molecular property prediction with auxiliary learning and task-specific adaptation.

Journal of cheminformatics·2024

Same author

Enhancing drug and cell line representations via contrastive learning for improved anti-cancer drug prioritization.

NPJ precision oncology·2024

Search research articles

Related Experiment Video

Updated: Jun 26, 2025

Assessing Specificity of Anticancer Drugs In Vitro

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

Improving Anticancer Drug Selection and Prioritization via Neural Learning to Rank.

Vishal Dey¹, Xia Ning^1,2,3

¹Department of Computer Science and Engineering, The Ohio State University, Columbus, Ohio 43210, United States.

Journal of Chemical Information and Modeling

|May 13, 2024

Summary

This summary is machine-generated.

New neural ranking models improve personalized cancer treatment by prioritizing effective drugs. These data-driven approaches outperform existing methods in identifying the best drug candidates for specific cancer cell lines.

More Related Videos

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Related Experiment Videos

Last Updated: Jun 26, 2025

Assessing Specificity of Anticancer Drugs In Vitro

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Area of Science:

Computational biology
Genomics
Pharmacology

Background:

Personalized cancer therapy necessitates understanding drug-cancer cell line interactions.
High-throughput screening generates large datasets for computational drug response modeling.
Accurate drug prioritization for individual cell lines remains a challenge.

Purpose of the Study:

To develop advanced neural ranking methods for improved drug prioritization in cancer treatment.
To address the limitations of regression and classification in predicting drug efficacy.
To formulate drug selection as a ranking problem using large-scale drug response data.

Main Methods:

Developed novel pairwise and listwise neural ranking models (Pair-PushC, List-One, List-All).
Leveraged large-scale drug response data across diverse cancer cell lines.
Learned latent representations of drugs and cell lines for scoring drug effectiveness.

Main Results:

Proposed ranking methods outperformed state-of-the-art baselines, improving drug selection by up to 25.6% (hit@20).
Learned latent spaces revealed informative clustering and captured biological features.
Comprehensive evaluation provided objective comparisons of various computational methods.

Conclusions:

Neural ranking approaches offer a powerful data-driven strategy for personalized cancer drug selection.
The developed methods enhance the accuracy and efficiency of identifying effective anti-cancer drugs.
Future research can leverage these models for improved clinical decision-making in oncology.